4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Concord Biotech Limited (CONCORDBIO) operates in the Biotechnology industry and is headquartered in Ahmedabad, India with about 1,624 employees. Its market capitalization is roughly ₹156 billion. In the fiscal year ended 2026-03-31, CONCORDBIO reported ₹10.5B in revenue and ₹2.6B in net income.
Concord Biotech Limited, a, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally. It operates through Active Pharmaceutical Ingredients (APIs) and Formulations segments.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹10.5B | ₹11.8B | ₹10.0B | ₹8.3B | — |
| Gross Profit | ₹7.9B | ₹8.6B | ₹7.6B | ₹6.3B | — |
| Operating Income (EBIT) | ₹3.0B | ₹4.6B | ₹3.9B | ₹3.0B | — |
| Net Income | ₹2.6B | ₹3.7B | ₹3.1B | ₹2.4B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | ₹2.6B | ₹3.3B | ₹2.8B | ₹2.5B | ₹2.0B | — | — |
| Gross Profit | ₹2.0B | ₹2.4B | ₹2.1B | ₹2.0B | ₹1.6B | — | — |
| Operating Income (EBIT) | ₹643M | ₹990M | ₹802M | ₹701M | ₹436M | — | — |
| Net Income | ₹577M | ₹888M | ₹636M | ₹631M | ₹441M | — | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹1.1B) | (₹915M) | (₹714M) | (₹536M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹22.3B | ₹20.3B | ₹17.0B | ₹15.1B | — |
| Total Liabilities | ₹2.2B | ₹2.2B | ₹1.7B | ₹2.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CONCORDBIO viewer.
About TickerBase · Data methodology & sources · Privacy · Terms